ArticleEBioMedicine2026
MechanoAge, a machine learning platform to identify individuals susceptible to breast cancer based on mechanical properties of single cells.
Article in EBioMedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
13 authors.
Funding
Abstract
backgroundEmerging evidence links cellular ageing and biophysical alterations with cancer susceptibility. Existing breast cancer risk models inadequately identify individuals at latent risk, particularly among women without known genetic mutations or family history. Risk is often underestimated or overestimated due to reliance on population-level data and absence of individualised tissue-based markers of breast cancer risk.
methodsWe profiled primary human mammary epithelial cells (HMECs) from women of varying ages and risk backgrounds using mechano-node-pore sensing (mechano-NPS), a high-throughput microfluidic platform that measures single-cell physical and mechanical properties. We developed a machine learning classifier, MechanoAge, to estimate chronological age based on mechanical phenotypes, and a biological age-based risk index, Mechano-RISQ. We further assessed cytoskeletal protein keratin 14 (KRT14) as a key mediator of underlying mechanical states through overexpression and knockdown experiments.
findingsEpithelial cells from normal tissue of young BRCA1/2 mutation carriers (n = 4), women with family history of breast cancer (n = 3), and tissue contralateral to a tumour-bearing breast (n = 9) exhibited elevated Mechano-RISQ scores, which reflects accelerated biological ageing compared to age-matched controls (n = 18). KRT14 overexpression induced a biologically aged phenotype in cells obtained from younger women, whereas knockdown partially reversed this state in cells from older women. CyTOF profiling and modelling showed KRT14 modulation impacted protein expression signatures associated with ageing and risk.
interpretationMechano-RISQ offers a proof of principle approach for identifying individuals at elevated risk of breast cancer, especially among average-risk populations, and may complement existing risk models by incorporating biophysical measures of mammary epithelial cell ageing.
fundingNIH R01EB024989, R01CA237602, and P30CA033572, DOD BC181737, American Cancer Society-Fred Ross Desert Spirit Postdoctoral Fellowship (PF-21-184-01-CSM).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.